Corona Remedies made a remarkable debut on the stock market, opening with a significant premium. The company's Rs 655-crore ...

Corona Remedies’ IPO is scheduled to debut on the stock exchanges today, December 15, following strong investor demand during ...

The company aims to raise ₹655.37 crore from the book-building issue, which is entirely an offer for sale of 61.71 lakh ...

Once the allotment is finalised, investors who applied for Corona Remedies IPO can check their status on the official ...

The initial public offering of Corona Remedies saw strong investor interest, being subscribed more than 137x from 8-10.

At a price band of Rs 1,008–1,062 per share and a lot size of 120 shares, the Rs 655.37-crore IPO triggered massive interest, ...

According to InvestorGain, the last grey market premium (GMP) for the Corona Remedies IPO stood at Rs 342.5 on Dec. 15. With ...

The IPO of Corona Remedies opens for subscription today, giving investors a chance to participate in one of the pharma sector’s fast-growing companies. Backed by ChrysCapital, the issue has already ...

Buford (Ga.) is the 2025 Super 25 National High School Football Champion after taking down No. 4 Carrollton in the Georgia ...

Corona Remedies IPO GMP Day 1, Subscription Status Live Updates: The initial public offering of Corona Remedies kicked off today, marking the first day of bidding for the Rs 655 crore issue. Investors ...

Two new companies, namely- Wakefit Innovations and Corona Remedies- are set to make their Dalal Street debut on Monday, ...

The two mainboard IPOs currently open for subscription are witnessing markedly different investor interest on Day 2. While ...